Allmed Solutions Ltd (TLV:ALMD)
Israel
· Delayed Price · Currency is ILS · Price in ILA 33.50
+1.00 (3.08%)
Apr 1, 2025, 4:11 PM IDT
Allmed Solutions Income Statement
Financials in millions ILS. Fiscal year is January - December.
Millions ILS. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Revenue | - | - | - | 5.55 | 9.72 | Upgrade
|
| Revenue Growth (YoY) | - | - | - | -42.95% | -12.81% | Upgrade
|
| Cost of Revenue | - | - | - | 2.46 | 4.35 | Upgrade
|
| Gross Profit | - | - | - | 3.08 | 5.37 | Upgrade
|
| Selling, General & Admin | 5.17 | 5.43 | 6.96 | 6.66 | 8.25 | Upgrade
|
| Research & Development | 5.9 | 5.24 | 5.33 | 5.6 | 6.92 | Upgrade
|
| Other Operating Expenses | - | 0.19 | 0.11 | -0.22 | 0.01 | Upgrade
|
| Operating Expenses | 11.07 | 10.85 | 12.41 | 12.04 | 15.18 | Upgrade
|
| Operating Income | -11.07 | -10.85 | -12.41 | -8.96 | -9.81 | Upgrade
|
| Interest Expense | -0.08 | -0.08 | -0.05 | -0.1 | -0.21 | Upgrade
|
| Interest & Investment Income | - | 1.75 | 0.02 | 0 | 0.01 | Upgrade
|
| Earnings From Equity Investments | - | -1.76 | -2.71 | -1.14 | - | Upgrade
|
| Currency Exchange Gain (Loss) | - | 0.46 | 2.05 | -1.01 | -0.99 | Upgrade
|
| Other Non Operating Income (Expenses) | 2.4 | 4.41 | 0.95 | -1.35 | -2.06 | Upgrade
|
| EBT Excluding Unusual Items | -8.75 | -6.08 | -12.15 | -12.54 | -13.06 | Upgrade
|
| Gain (Loss) on Sale of Investments | - | -4.94 | - | -0.22 | - | Upgrade
|
| Gain (Loss) on Sale of Assets | - | 12.61 | - | 18.85 | 3.88 | Upgrade
|
| Other Unusual Items | - | -0.17 | 0.01 | -3.39 | -0.07 | Upgrade
|
| Pretax Income | -8.75 | 1.42 | -12.14 | 2.7 | -9.25 | Upgrade
|
| Earnings From Continuing Operations | -8.75 | 1.42 | -12.14 | 2.7 | -9.25 | Upgrade
|
| Minority Interest in Earnings | - | - | - | 0.11 | 0.59 | Upgrade
|
| Net Income | -8.75 | 1.42 | -12.14 | 2.81 | -8.66 | Upgrade
|
| Net Income to Common | -8.75 | 1.42 | -12.14 | 2.81 | -8.66 | Upgrade
|
| Shares Outstanding (Basic) | 97 | 108 | 88 | 81 | 80 | Upgrade
|
| Shares Outstanding (Diluted) | 97 | 108 | 88 | 81 | 80 | Upgrade
|
| Shares Change (YoY) | -10.11% | 23.15% | 8.97% | 0.37% | 0.25% | Upgrade
|
| EPS (Basic) | -0.09 | 0.01 | -0.14 | 0.03 | -0.11 | Upgrade
|
| EPS (Diluted) | -0.09 | 0.01 | -0.14 | 0.03 | -0.11 | Upgrade
|
| Free Cash Flow | -8.14 | 7.02 | -10.65 | -5.52 | -8.95 | Upgrade
|
| Free Cash Flow Per Share | -0.08 | 0.07 | -0.12 | -0.07 | -0.11 | Upgrade
|
| Gross Margin | - | - | - | 55.60% | 55.26% | Upgrade
|
| Operating Margin | - | - | - | -161.55% | -100.89% | Upgrade
|
| Profit Margin | - | - | - | 50.64% | -89.08% | Upgrade
|
| Free Cash Flow Margin | - | - | - | -99.57% | -92.06% | Upgrade
|
| EBITDA | -10.51 | -10.7 | -12.31 | -7.9 | -7.95 | Upgrade
|
| EBITDA Margin | - | - | - | -142.40% | -81.80% | Upgrade
|
| D&A For EBITDA | 0.56 | 0.15 | 0.1 | 1.06 | 1.86 | Upgrade
|
| EBIT | -11.07 | -10.85 | -12.41 | -8.96 | -9.81 | Upgrade
|
| EBIT Margin | - | - | - | -161.55% | -100.89% | Upgrade
|
| Advertising Expenses | - | - | - | - | 0.17 | Upgrade
|
Updated Aug 13, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.